He, L. 2023. SGLT2 Inhibitor And GLP-1 Receptor Agonist in Type 2 Diabetes Mellitus Patients. Research on Their Cardiovascular Benefits. Highlights in Science, Engineering and Technology. 74, (Dec. 2023), 1717–1722. DOI:https://doi.org/10.54097/m9vm2798.